{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:26:31Z","timestamp":1773739591454,"version":"3.50.1"},"reference-count":120,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100005150","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-028"],"award-info":[{"award-number":["2021-I2M-1-028"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-027"],"award-info":[{"award-number":["2021-I2M-1-027"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973290"],"award-info":[{"award-number":["81973290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173888"],"award-info":[{"award-number":["82173888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK\/PD study","award":["Z141102004414062"],"award-info":[{"award-number":["Z141102004414062"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Atherosclerosis (AS) is one of the major risk factors for cardiovascular disease pathogenesis, and current\nstudies have found that the development of atherosclerosis is closely related to the intestinal microbiome. This review\ndescribes the relationship between the development of atherosclerosis and the gut microbiome with its metabolites\nand reviews the interactions between atherosclerosis-related drugs and the intestinal microbiome, especially the\nin vivo metabolic effects of the intestinal microbiome on drugs related to the treatment of atherosclerosis, to provide\nfurther understanding for the development of drugs based on the intestinal microbiome to treat atherosclerosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389200224666230410094806","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T04:24:15Z","timestamp":1681187055000},"page":"482-492","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug-gut Microbiome Interaction in Atherosclerosis Therapeutics"],"prefix":"10.2174","volume":"24","author":[{"given":"Hao-Jian","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences\/Peking Union Medical College, Beijing, 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of\nMedical Sciences\/Peking Union Medical College, Beijing, 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Dong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences\/Peking Union Medical College, Beijing, 100050, China"},{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of\nMedical Sciences\/Peking Union Medical College, Beijing, 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vph.2018.08.002","volume":"112","author":"Maguire E.M.","year":"2019","unstructured":"Maguire E.M.; Pearce S.W.A.; Xiao Q.; Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease. Vascul Pharmacol 2019,112,54-71","journal-title":"Vascul Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","volume":"140","author":"Arnett D.K.","year":"2019","unstructured":"Arnett D.K.; Blumenthal R.S.; Albert M.A.; Buroker A.B.; Goldberger Z.D.; Hahn E.J.; Himmelfarb C.D.; Khera A.; Lloyd-Jones D.; McEvoy J.W.; Michos E.D.; Miedema M.D.; Mu\u00f1oz D.; Smith S.C.; Virani S.S.; Williams K.A.; Yeboah J.; Ziaeian B.; 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines. Circulation 2019,140(11),e596-e646","journal-title":"Circulation"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.3390\/ijms20215296","volume":"20","author":"Sittipo P.","year":"2019","unstructured":"Sittipo P.; Shim J.; Lee Y.; Microbial metabolites determine host health and the status of some diseases. Int J Mol Sci 2019,20(21),5296","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1539595","DOI":"10.1080\/21688370.2018.1539595","volume":"6","author":"Alam A.","year":"2018","unstructured":"Alam A.; Neish A.; Role of gut microbiota in intestinal wound healing and barrier function. Tissue Barriers 2018,6(3),1539595","journal-title":"Tissue Barriers"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/nu2111106","volume":"2","author":"Vauzour D.","year":"2010","unstructured":"Vauzour D.; Rodriguez-Mateos A.; Corona G.; Oruna-Concha M.J.; Spencer J.P.E.; Polyphenols and human health: Prevention of dis-ease and mechanisms of action. Nutrients 2010,2(11),1106-1131","journal-title":"Nutrients"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"Rowland I.","year":"2018","unstructured":"Rowland I.; Gibson G.; Heinken A.; Scott K.; Swann J.; Thiele I.; Tuohy K.; Gut microbiota functions: Metabolism of nutrients and other food components. Eur J Nutr 2018,57(1),1-24","journal-title":"Eur J Nutr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Jie Z.","year":"2017","unstructured":"Jie Z.; Xia H.; Zhong S.L.; Feng Q.; Li S.; Liang S.; Zhong H.; Liu Z.; Gao Y.; Zhao H.; Zhang D.; Su Z.; Fang Z.; Lan Z.; Li J.; Xiao L.; Li J.; Li R.; Li X.; Li F.; Ren H.; Huang Y.; Peng Y.; Li G.; Wen B.; Dong B.; Chen J.Y.; Geng Q.S.; Zhang Z.W.; Yang H.; Wang J.; Wang J.; Zhang X.; Madsen L.; Brix S.; Ning G.; Xu X.; Liu X.; Hou Y.; Jia H.; He K.; Kristiansen K.; The gut micro-biome in atherosclerotic cardiovascular disease. Nat Commun 2017,8(1),845","journal-title":"Nat Commun"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","volume":"374","author":"Pernigoni N.","year":"2021","unstructured":"Pernigoni N.; Zagato E.; Calcinotto A.; Troiani M.; Mestre R.P.; Cal\u00ec B.; Attanasio G.; Troisi J.; Minini M.; Mosole S.; Revandkar A.; Pasquini E.; Elia A.R.; Bossi D.; Rinaldi A.; Rescigno P.; Flohr P.; Hunt J.; Neeb A.; Buroni L.; Guo C.; Welti J.; Ferrari M.; Grioni M.; Gauthier J.; Gharaibeh R.Z.; Palmisano A.; Lucchini G.M.; D\u2019Antonio E.; Merler S.; Bolis M.; Grassi F.; Esposito A.; Bellone M.; Briganti A.; Rescigno M.; Theurillat J.P.; Jobin C.; Gillessen S.; de Bono J.; Alimonti A.; Commensal bacteria promote en-docrine resistance in prostate cancer through androgen biosynthesis. Science 2021,374(6564),216-224","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e16626","DOI":"10.1097\/MD.0000000000016626","volume":"98","author":"Liang W.","year":"2019","unstructured":"Liang W.; Yang Y.; Wang H.; Wang H.; Yu X.; Lu Y.; Shen S.; Teng L.; Gut microbiota shifts in patients with gastric cancer in perioperative period. Medicine 2019,98(35),e16626","journal-title":"Medicine"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"Zhang X.","year":"2021","unstructured":"Zhang X.; Coker O.O.; Chu E.S.H.; Fu K.; Lau H.C.H.; Wang Y.X.; Chan A.W.H.; Wei H.; Yang X.; Sung J.J.Y.; Yu J.; Dietary cho-lesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 2021,70(4),761-774","journal-title":"Gut"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","volume":"2","author":"Halfvarson J.","year":"2017","unstructured":"Halfvarson J.; Brislawn C.J.; Lamendella R.; V\u00e1zquez-Baeza Y.; Walters W.A.; Bramer L.M.; D\u2019Amato M.; Bonfiglio F.; McDonald D.; Gonzalez A.; McClure E.E.; Dunklebarger M.F.; Knight R.; Jansson J.K.; Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol 2017,2(5),17004","journal-title":"Nat Microbiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","volume":"67","author":"Imhann F.","year":"2018","unstructured":"Imhann F.; Vich Vila A.; Bonder M.J.; Fu J.; Gevers D.; Visschedijk M.C.; Spekhorst L.M.; Alberts R.; Franke L.; van Dullemen H.M.; Ter Steege R.W.F.; Huttenhower C.; Dijkstra G.; Xavier R.J.; Festen E.A.M.; Wijmenga C.; Zhernakova A.; Weersma R.K.; In-terplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 2018,67(1),108-119","journal-title":"Gut"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"Franzosa E.A.","year":"2018","unstructured":"Franzosa E.A.; Sirota-Madi A.; Avila-Pacheco J.; Fornelos N.; Haiser H.J.; Reinker S.; Vatanen T.; Hall A.B.; Mallick H.; McIver L.J.; Sauk J.S.; Wilson R.G.; Stevens B.W.; Scott J.M.; Pierce K.; Deik A.A.; Bullock K.; Imhann F.; Porter J.A.; Zhernakova A.; Fu J.; Weersma R.K.; Wijmenga C.; Clish C.B.; Vlamakis H.; Huttenhower C.; Xavier R.J.; Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol 2018,4(2),293-305","journal-title":"Nat Microbiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"Sampson T.R.","year":"2016","unstructured":"Sampson T.R.; Debelius J.W.; Thron T.; Janssen S.; Shastri G.G.; Ilhan Z.E.; Challis C.; Schretter C.E.; Rocha S.; Gradinaru V.; Chesselet M.F.; Keshavarzian A.; Shannon K.M.; Krajmalnik-Brown R.; Wittung-Stafshede P.; Knight R.; Mazmanian S.K.; Gut micro-biota regulate motor deficits and neuroinflammation in a model of parkinson\u2019s disease. Cell 2016,167(6),1469-1480.e12","journal-title":"Cell"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"Kim M.S.","year":"2020","unstructured":"Kim M.S.; Kim Y.; Choi H.; Kim W.; Park S.; Lee D.; Kim D.K.; Kim H.J.; Choi H.; Hyun D.W.; Lee J.Y.; Choi E.Y.; Lee D.S.; Bae J.W.; Mook-Jung I.; Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 2020,69(2),283-294","journal-title":"Gut"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"Chen C.","year":"2022","unstructured":"Chen C.; Liao J.; Xia Y.; Liu X.; Jones R.; Haran J.; McCormick B.; Sampson T.R.; Alam A.; Ye K.; Gut microbiota regulate Alz-heimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut 2022,71(11),2233-2252","journal-title":"Gut"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCRESAHA.118.313234","volume":"124","author":"Brandsma E.","year":"2019","unstructured":"Brandsma E.; Kloosterhuis N.J.; Koster M.; Dekker D.C.; Gijbels M.J.J.; van der Velden S.; R\u00edos-Morales M.; van Faassen M.J.R.; Loreti M.G.; de Bruin A.; Fu J.; Kuipers F.; Bakker B.M.; Westerterp M.; de Winther M.P.J.; Hofker M.H.; van de Sluis B.; Koonen D.P.Y.; A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis. Circ Res 2019,124(1),94-100","journal-title":"Circ Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"102115","DOI":"10.1016\/j.redox.2021.102115","volume":"46","author":"Jiang S.","year":"2021","unstructured":"Jiang S.; Shui Y.; Cui Y.; Tang C.; Wang X.; Qiu X.; Hu W.; Fei L.; Li Y.; Zhang S.; Zhao L.; Xu N.; Dong F.; Ren X.; Liu R.; Persson P.B.; Patzak A.; Lai E.Y.; Wei Q.; Zheng Z.; Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II\u2013induced hypertension. Redox Biol 2021,46,102115","journal-title":"Redox Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","volume":"7","author":"Liu H.","year":"2019","unstructured":"Liu H.; Chen X.; Hu X.; Niu H.; Tian R.; Wang H.; Pang H.; Jiang L.; Qiu B.; Chen X.; Zhang Y.; Ma Y.; Tang S.; Li H.; Feng S.; Zhang S.; Zhang C.; Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome 2019,7(1),68","journal-title":"Microbiome"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"Yang T.","year":"2015","unstructured":"Yang T.; Santisteban M.M.; Rodriguez V.; Li E.; Ahmari N.; Carvajal J.M.; Zadeh M.; Gong M.; Qi Y.; Zubcevic J.; Sahay B.; Pep-ine C.J.; Raizada M.K.; Mohamadzadeh M.; Gut dysbiosis is linked to hypertension. Hypertension 2015,65(6),1331-1340","journal-title":"Hypertension"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1152\/physiolgenomics.00081.2016","volume":"49","author":"Adnan S.","year":"2017","unstructured":"Adnan S.; Nelson J.W.; Ajami N.J.; Venna V.R.; Petrosino J.F.; Bryan R.M.; Durgan D.J.; Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genomics 2017,49(2),96-104","journal-title":"Physiol Genomics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1194\/jlr.M072165","volume":"58","author":"Kasahara K.","year":"2017","unstructured":"Kasahara K.; Tanoue T.; Yamashita T.; Yodoi K.; Matsumoto T.; Emoto T.; Mizoguchi T.; Hayashi T.; Kitano N.; Sasaki N.; Ata-rashi K.; Honda K.; Hirata K.; Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in ather-osclerosis. J Lipid Res 2017,58(3),519-528","journal-title":"J Lipid Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5551\/jat.3285","volume":"17","author":"Stepankova R.","year":"2010","unstructured":"Stepankova R.; Tonar Z.; Bartova J.; Nedorost L.; Rossman P.; Poledne R.; Schwarzer M.; Tlaskalova-Hogenova H.; Absence of mi-crobiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb 2010,17(8),796-804","journal-title":"J Atheroscler Thromb"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1161\/ATVBAHA.118.311233","volume":"38","author":"Lindskog Jonsson A.","year":"2018","unstructured":"Lindskog Jonsson A.; Caesar R.; Akrami R.; Reinhardt C.; F\u00e5k H\u00e5llenius F.; Bor\u00e9n J.; B\u00e4ckhed F.; Impact of gut microbiota and diet on the development of atherosclerosis in Apoe\u2212\/\u2212 Mice. Arterioscler Thromb Vasc Biol 2018,38(10),2318-2326","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/19490976.2019.1634416","volume":"11","author":"Guzm\u00e1n-Casta\u00f1eda S.J.","year":"2020","unstructured":"Guzm\u00e1n-Casta\u00f1eda S.J.; Ortega-Vega E.L.; de la Cuesta-Zuluaga J.; Vel\u00e1squez-Mej\u00eda E.P.; Rojas W.; Bedoya G.; Escobar J.S.; Gut microbiota composition explains more variance in the host cardiometabolic risk than genetic ancestry. Gut Microbes 2020,11(2),191-204","journal-title":"Gut Microbes"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1161\/CIRCRESAHA.116.309219","volume":"119","author":"Kelly T.N.","year":"2016","unstructured":"Kelly T.N.; Bazzano L.A.; Ajami N.J.; He H.; Zhao J.; Petrosino J.F.; Correa A.; He J.; Gut microbiome associates with lifetime cardi-ovascular disease risk profile among bogalusa heart study participants. Circ Res 2016,119(8),956-964","journal-title":"Circ Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"Pasini E.","year":"2016","unstructured":"Pasini E.; Aquilani R.; Testa C.; Baiardi P.; Angioletti S.; Boschi F.; Verri M.; Dioguardi F.; Pathogenic gut flora in patients with chron-ic heart failure. JACC Heart Fail 2016,4(3),220-227","journal-title":"JACC Heart Fail"},{"key":"ref=28","first-page":"24","volume":"36","author":"Zhao H.","year":"2020","unstructured":"Zhao H.; Chen L.; He C.; Li S.; Yang H.; Xu X.; Hu F.; Cui Z.; Liu Q.; Chronic Staphylococcus aureus superantigen toxic shock syn-drome toxin-1 exposure accelerates the progression of atherosclerosis in rabbits. Zhonghua Minguo Xinzangxue Hui Zazhi 2020,36(1),24-32","journal-title":"Zhonghua Minguo Xinzangxue Hui Zazhi"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e02298","DOI":"10.1128\/mBio.02298-19","volume":"10","author":"Kiouptsi K.","year":"2019","unstructured":"Kiouptsi K.; J\u00e4ckel S.; Pontarollo G.; Grill A.; Kuijpers M.J.E.; Wilms E.; Weber C.; Sommer F.; Nagy M.; Neideck C.; Jansen Y.; Ascher S.; Formes H.; Karwot C.; Bayer F.; Kollar B.; Subramaniam S.; Molitor M.; Wenzel P.; Rosenstiel P.; Todorov H.; Gerber S.; Walter U.; Jurk K.; Heemskerk J.W.M.; van der Vorst E.P.C.; D\u00f6ring Y.; Reinhardt C.; The microbiota promotes arterial thrombosis in low-density lipoprotein receptor-deficient mice. MBio 2019,10(5),e02298-e19","journal-title":"MBio"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"63437","DOI":"10.18632\/oncotarget.11521","volume":"7","author":"Zhang X.","year":"2016","unstructured":"Zhang X.; Zhu X.; Wang C.; Zhang H.; Cai Z.; Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and pre-dicting patient prognosis. Oncotarget 2016,7(39),63437-63448","journal-title":"Oncotarget"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Wang Z.","year":"2014","unstructured":"Wang Z.; Tang W.H.W.; Buffa J.A.; Fu X.; Britt E.B.; Koeth R.A.; Levison B.S.; Fan Y.; Wu Y.; Hazen S.L.; Prognostic value of cho-line and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J 2014,35(14),904-910","journal-title":"Eur Heart J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Wang Z.","year":"2015","unstructured":"Wang Z.; Roberts A.B.; Buffa J.A.; Levison B.S.; Zhu W.; Org E.; Gu X.; Huang Y.; Zamanian-Daryoush M.; Culley M.K.; DiDona-to A.J.; Fu X.; Hazen J.E.; Krajcik D.; DiDonato J.A.; Lusis A.J.; Hazen S.L.; Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 2015,163(7),1585-1595","journal-title":"Cell"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1021\/cb500113p","volume":"9","author":"Craciun S.","year":"2014","unstructured":"Craciun S.; Marks J.A.; Balskus E.P.; Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes. ACS Chem Biol 2014,9(7),1408-1413","journal-title":"ACS Chem Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1073\/pnas.1316569111","volume":"111","author":"Zhu Y.","year":"2014","unstructured":"Zhu Y.; Jameson E.; Crosatti M.; Sch\u00e4fer H.; Rajakumar K.; Bugg T.D.H.; Chen Y.; Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci 2014,111(11),4268-4273","journal-title":"Proc Natl Acad Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF00871641","volume":"66","author":"Andreesen J.R.","year":"1994","unstructured":"Andreesen J.R.; Glycine metabolism in anaerobes. Antonie van Leeuwenhoek 1994,66(1-3),223-237","journal-title":"Antonie van Leeuwenhoek"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF00332770","volume":"195","author":"Pascal M.C.","year":"1984","unstructured":"Pascal M.C.; Burini J.F.; Chippaux M.; Regulation of the trimethylamine N-oxide (TMAO) reductase in Escherichia coli: Analysis of tor:Mud1 operon fusion. Mol Gen Genet 1984,195(1-2),351-355","journal-title":"Mol Gen Genet"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","volume":"20","author":"Koeth R.A.","year":"2014","unstructured":"Koeth R.A.; Levison B.S.; Culley M.K.; Buffa J.A.; Wang Z.; Gregory J.C.; Org E.; Wu Y.; Li L.; Smith J.D.; Tang W.H.W.; DiDona-to J.A.; Lusis A.J.; Hazen S.L.; \u03b3-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab 2014,20(5),799-812","journal-title":"Cell Metab"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"Koeth R.A.","year":"2013","unstructured":"Koeth R.A.; Wang Z.; Levison B.S.; Buffa J.A.; Org E.; Sheehy B.T.; Britt E.B.; Fu X.; Wu Y.; Li L.; Smith J.D.; DiDonato J.A.; Chen J.; Li H.; Wu G.D.; Lewis J.D.; Warrier M.; Brown J.M.; Krauss R.M.; Tang W.H.W.; Bushman F.D.; Lusis A.J.; Hazen S.L.; Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013,19(5),576-585","journal-title":"Nat Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Wang Z.","year":"2011","unstructured":"Wang Z.; Klipfell E.; Bennett B.J.; Koeth R.; Levison B.S.; DuGar B.; Feldstein A.E.; Britt E.B.; Fu X.; Chung Y.M.; Wu Y.; Schau-er P.; Smith J.D.; Allayee H.; Tang W.H.W.; DiDonato J.A.; Lusis A.J.; Hazen S.L.; Gut flora metabolism of phosphatidylcholine pro-motes cardiovascular disease. Nature 2011,472(7341),57-63","journal-title":"Nature"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","volume":"6","author":"Romano K.A.","year":"2015","unstructured":"Romano K.A.; Vivas E.I.; Amador-Noguez D.; Rey F.E.; Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio 2015,6(2),e02481-e14","journal-title":"MBio"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.2174\/1381612823666170622095324","volume":"23","author":"Oellgaard J.","year":"2017","unstructured":"Oellgaard J.; Winther S.A.; Hansen T.S.; Rossing P.; von Scholten B.J.; Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer. Curr Pharm Des 2017,23(25),3699-3712","journal-title":"Curr Pharm Des"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/joim.12328","volume":"277","author":"Tr\u00f8seid M.","year":"2015","unstructured":"Tr\u00f8seid M.; Ueland T.; Hov J.R.; Svardal A.; Gregersen I.; Dahl C.P.; Aakhus S.; Gude E.; Bj\u00f8rndal B.; Halvorsen B.; Karlsen T.H.; Aukrust P.; Gullestad L.; Berge R.K.; Yndestad A.; Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med 2015,277(6),717-726","journal-title":"J Intern Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10753-015-0261-7","volume":"39","author":"Mohammadi A.","year":"2016","unstructured":"Mohammadi A.; Najar A.G.; Yaghoobi M.M.; Jahani Y.; Vahabzadeh Z.; Trimethylamine-N-oxide treatment induces changes in the ATP-binding cassette transporter A1 and scavenger receptor A1 in murine macrophage J774A.1 cells. Inflammation 2016,39(1),393-404","journal-title":"Inflammation"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","volume":"10","author":"Warrier M.","year":"2015","unstructured":"Warrier M.; Shih D.M.; Burrows A.C.; Ferguson D.; Gromovsky A.D.; Brown A.L.; Marshall S.; McDaniel A.; Schugar R.C.; Wang Z.; Sacks J.; Rong X.; Vallim T.A.; Chou J.; Ivanova P.T.; Myers D.S.; Brown H.A.; Lee R.G.; Crooke R.M.; Graham M.J.; Liu X.; Parini P.; Tontonoz P.; Lusis A.J.; Hazen S.L.; Temel R.E.; Brown J.M.; The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep 2015,10(3),326-338","journal-title":"Cell Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.120.14759","volume":"76","author":"Brunt V.E.","year":"2020","unstructured":"Brunt V.E.; Gioscia-Ryan R.A.; Casso A.G.; VanDongen N.S.; Ziemba B.P.; Sapinsley Z.J.; Richey J.J.; Zigler M.C.; Neilson A.P.; Davy K.P.; Seals D.R.; Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans. Hypertension 2020,76(1),101-112","journal-title":"Hypertension"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e006347","DOI":"10.1161\/JAHA.117.006347","volume":"6","author":"Chen M.","year":"2017","unstructured":"Chen M.; Zhu X.; Ran L.; Lang H.; Yi L.; Mi M.; Trimethylamine\u2010N\u2010oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3\u2010SOD2\u2010mtROS signaling pathway. J Am Heart Assoc 2017,6(9),e006347","journal-title":"J Am Heart Assoc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e002767","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"Seldin M.M.","year":"2016","unstructured":"Seldin M.M.; Meng Y.; Qi H.; Zhu W.; Wang Z.; Hazen S.L.; Lusis A.J.; Shih D.M.; Trimethylamine N\u2010Oxide promotes vascular in-flammation through signaling of mitogen\u2010activated protein kinase and nuclear factor\u2010\u03baB. J Am Heart Assoc 2016,5(2),e002767","journal-title":"J Am Heart Assoc"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"Rooks M.G.","year":"2016","unstructured":"Rooks M.G.; Garrett W.S.; Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016,16(6),341-352","journal-title":"Nat Rev Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.7150\/thno.40571","volume":"10","author":"Hu Z.B.","year":"2020","unstructured":"Hu Z.B.; Lu J.; Chen P.P.; Lu C.C.; Zhang J.X.; Li X.Q.; Yuan B.Y.; Huang S.J.; Ruan X.Z.; Liu B.C.; Ma K.L.; Dysbiosis of intesti-nal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis. Theranostics 2020,10(6),2803-2816","journal-title":"Theranostics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","volume":"43","author":"Haghikia A.","year":"2022","unstructured":"Haghikia A.; Zimmermann F.; Schumann P.; Jasina A.; Roessler J.; Schmidt D.; Heinze P.; Kaisler J.; Nageswaran V.; Aigner A.; Ceglarek U.; Cineus R.; Hegazy A.N.; van der Vorst E.P.C.; D\u00f6ring Y.; Strauch C.M.; Nemet I.; Tremaroli V.; Dwibedi C.; Kr\u00e4nkel N.; Leistner D.M.; Heimesaat M.M.; Bereswill S.; Rauch G.; Seeland U.; Soehnlein O.; M\u00fcller D.N.; Gold R.; B\u00e4ckhed F.; Hazen S.L.; Haghikia A.; Landmesser U.; Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metab-olism. Eur Heart J 2022,43(6),518-533","journal-title":"Eur Heart J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","volume":"24","author":"Aguilar E.C.","year":"2014","unstructured":"Aguilar E.C.; Leonel A.J.; Teixeira L.G.; Silva A.R.; Silva J.F.; Pelaez J.M.N.; Capettini L.S.A.; Lemos V.S.; Santos R.A.S.; Alvarez-Leite J.I.; Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NF\u03baB activation. Nutr Metab Cardiovasc Dis 2014,24(6),606-613","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jnutbio.2016.05.002","volume":"34","author":"Aguilar E.C.","year":"2016","unstructured":"Aguilar E.C.; Santos L.C.; Leonel A.J.; de Oliveira J.S.; Santos E.A.; Navia-Pelaez J.M.; da Silva J.F.; Mendes B.P.; Capettini L.S.A.; Teixeira L.G.; Lemos V.S.; Alvarez-Leite J.I.; Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism in-volving NADPH oxidase down-regulation in endothelial cells. J Nutr Biochem 2016,34,99-105","journal-title":"J Nutr Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","volume":"139","author":"Tang T.W.H.","year":"2019","unstructured":"Tang T.W.H.; Chen H.C.; Chen C.Y.; Yen C.Y.T.; Lin C.J.; Prajnamitra R.P.; Chen L.L.; Ruan S.C.; Lin J.H.; Lin P.J.; Lu H.H.; Kuo C.W.; Chang C.M.; Hall A.D.; Vivas E.I.; Shui J.W.; Chen P.; Hacker T.A.; Rey F.E.; Kamp T.J.; Hsieh P.C.H.; Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation 2019,139(5),647-659","journal-title":"Circulation"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e00402","DOI":"10.1128\/AEM.00402-19","volume":"85","author":"Neijat M.","year":"2019","unstructured":"Neijat M.; Habtewold J.; Shirley R.B.; Welsher A.; Barton J.; Thiery P.; Kiarie E.; Bacillus subtilis strain DSM 29784 modulates the cecal microbiome, concentration of short-chain fatty acids, and apparent retention of dietary components in shaver white chickens during grower, developer, and laying phases. Appl Environ Microbiol 2019,85(14),e00402-e00419","journal-title":"Appl Environ Microbiol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"104403","DOI":"10.1016\/j.phrs.2019.104403","volume":"148","author":"Chen R.","year":"2019","unstructured":"Chen R.; Xu Y.; Wu P.; Zhou H.; Lasanajak Y.; Fang Y.; Tang L.; Ye L.; Li X.; Cai Z.; Zhao J.; Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota. Pharmacol Res 2019,148,104403","journal-title":"Pharmacol Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"Chiang J.Y.L.","year":"2009","unstructured":"Chiang J.Y.L.; Bile acids: Regulation of synthesis. J Lipid Res 2009,50(10),1955-1966","journal-title":"J Lipid Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","volume":"66","author":"Li T.","year":"2014","unstructured":"Li T.; Chiang J.Y.L.; Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014,66(4),948-983","journal-title":"Pharmacol Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"Ridlon J.M.","year":"2006","unstructured":"Ridlon J.M.; Kang D.J.; Hylemon P.B.; Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006,47(2),241-259","journal-title":"J Lipid Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12010-009-8738-1","volume":"162","author":"Patel A.K.","year":"2010","unstructured":"Patel A.K.; Singhania R.R.; Pandey A.; Chincholkar S.B.; Probiotic bile salt hydrolase: Current developments and perspectives. Appl Biochem Biotechnol 2010,162(1),166-180","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e37182","DOI":"10.7554\/eLife.37182","volume":"7","author":"Yao L.","year":"2018","unstructured":"Yao L.; Seaton S.C.; Ndousse-Fetter S.; Adhikari A.A.; DiBenedetto N.; Mina A.I.; Banks A.S.; Bry L.; Devlin A.S.; A selective gut bacterial bile salt hydrolase alters host metabolism. eLife 2018,7,e37182","journal-title":"eLife"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/hep.29199","volume":"66","author":"Kim K.H.","year":"2017","unstructured":"Kim K.H.; Choi S.; Zhou Y.; Kim E.Y.; Lee J.M.; Saha P.K.; Anakk S.; Moore D.D.; Hepatic FXR\/SHP axis modulates systemic glu-cose and fatty acid homeostasis in aged mice. Hepatology 2017,66(2),498-509","journal-title":"Hepatology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","volume":"12","author":"Guan B.","year":"2022","unstructured":"Guan B.; Tong J.; Hao H.; Yang Z.; Chen K.; Xu H.; Wang A.; Bile acid coordinates microbiota homeostasis and systemic immunome-tabolism in cardiometabolic diseases. Acta Pharm Sin B 2022,12(5),2129-2149","journal-title":"Acta Pharm Sin B"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e142865","DOI":"10.1172\/JCI142865","volume":"131","author":"Wu Q.","year":"2021","unstructured":"Wu Q.; Sun L.; Hu X.; Wang X.; Xu F.; Chen B.; Liang X.; Xia J.; Wang P.; Aibara D.; Zhang S.; Zeng G.; Yun C.; Yan Y.; Zhu Y.; Bustin M.; Zhang S.; Gonzalez F.J.; Jiang C.; Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis. J Clin Invest 2021,131(9),e142865","journal-title":"J Clin Invest"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/hep.30810","volume":"71","author":"Schumacher J.D.","year":"2020","unstructured":"Schumacher J.D.; Kong B.; Wu J.; Rizzolo D.; Armstrong L.E.; Chow M.D.; Goedken M.; Lee Y.H.; Guo G.L.; Direct and indirect effects of fibroblast growth factor (FGF) 15 and FGF19 on liver fibrosis development. Hepatology 2020,71(2),670-685","journal-title":"Hepatology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.28712","volume":"64","author":"Xu Y.","year":"2016","unstructured":"Xu Y.; Li F.; Zalzala M.; Xu J.; Gonzalez F.J.; Adorini L.; Lee Y.K.; Yin L.; Zhang Y.; Farnesoid X receptor activation increases re-verse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology 2016,64(4),1072-1085","journal-title":"Hepatology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","volume":"10","author":"Huang F.","year":"2019","unstructured":"Huang F.; Zheng X.; Ma X.; Jiang R.; Zhou W.; Zhou S.; Zhang Y.; Lei S.; Wang S.; Kuang J.; Han X.; Wei M.; You Y.; Li M.; Li Y.; Liang D.; Liu J.; Chen T.; Yan C.; Wei R.; Rajani C.; Shen C.; Xie G.; Bian Z.; Li H.; Zhao A.; Jia W.; Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun 2019,10(1),4971","journal-title":"Nat Commun"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"Sayin S.I.","year":"2013","unstructured":"Sayin S.I.; Wahlstr\u00f6m A.; Felin J.; J\u00e4ntti S.; Marschall H.U.; Bamberg K.; Angelin B.; Hy\u00f6tyl\u00e4inen T.; Ore\u0161i\u010d M.; B\u00e4ckhed F.; Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013,17(2),225-235","journal-title":"Cell Metab"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","volume":"71","author":"Raetz C.R.H.","year":"2002","unstructured":"Raetz C.R.H.; Whitfield C.; Lipopolysaccharide endotoxins. Annu Rev Biochem 2002,71(1),635-700","journal-title":"Annu Rev Biochem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"Michelsen K.S.","year":"2004","unstructured":"Michelsen K.S.; Wong M.H.; Shah P.K.; Zhang W.; Yano J.; Doherty T.M.; Akira S.; Rajavashisth T.B.; Arditi M.; Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci 2004,101(29),10679-10684","journal-title":"Proc Natl Acad Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1152\/physiol.00041.2015","volume":"31","author":"Saad M.J.A.","year":"2016","unstructured":"Saad M.J.A.; Santos A.; Prada P.O.; Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda) 2016,31(4),283-293","journal-title":"Physiology (Bethesda)"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"Lu Y.C.","year":"2008","unstructured":"Lu Y.C.; Yeh W.C.; Ohashi P.S.; LPS\/TLR4 signal transduction pathway. Cytokine 2008,42(2),145-151","journal-title":"Cytokine"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","volume":"353","author":"Niebauer J.","year":"1999","unstructured":"Niebauer J.; Volk H.D.; Kemp M.; Dominguez M.; Schumann R.R.; Rauchhaus M.; Poole-Wilson P.A.; Coats A.J.S.; Anker S.D.; Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 1999,353(9167),1838-1842","journal-title":"Lancet"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"e005784","DOI":"10.1161\/JAHA.117.005784","volume":"6","author":"Pastori D.","year":"2017","unstructured":"Pastori D.; Carnevale R.; Nocella C.; Novo M.; Santulli M.; Cammisotto V.; Menichelli D.; Pignatelli P.; Violi F.; Gut\u2010derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: Effect of adherence to mediterranean diet. J Am Heart Assoc 2017,6(6),e005784","journal-title":"J Am Heart Assoc"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/S0021-9258(17)33444-0","volume":"251","author":"Webster L.T.","year":"1976","unstructured":"Webster L.T.; Siddiqui U.A.; Lucas S.V.; Strong J.M.; Mieyal J.J.; Identification of separate acyl- CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. J Biol Chem 1976,251(11),3352-3358","journal-title":"J Biol Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"Dodd D.","year":"2017","unstructured":"Dodd D.; Spitzer M.H.; Van Treuren W.; Merrill B.D.; Hryckowian A.J.; Higginbottom S.K.; Le A.; Cowan T.M.; Nolan G.P.; Fisch-bach M.A.; Sonnenburg J.L.; A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 2017,551(7682),648-652","journal-title":"Nature"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"Nemet I.","year":"2020","unstructured":"Nemet I.; Saha P.P.; Gupta N.; Zhu W.; Romano K.A.; Skye S.M.; Cajka T.; Mohan M.L.; Li L.; Wu Y.; Funabashi M.; Ramer-Tait A.E.; Naga Prasad S.V.; Fiehn O.; Rey F.E.; Tang W.H.W.; Fischbach M.A.; DiDonato J.A.; Hazen S.L.; A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 2020,180(5),862-877.e22","journal-title":"Cell"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e008342","DOI":"10.1161\/JAHA.117.008342","volume":"7","author":"Smits L.P.","year":"2018","unstructured":"Smits L.P.; Kootte R.S.; Levin E.; Prodan A.; Fuentes S.; Zoetendal E.G.; Wang Z.; Levison B.S.; Cleophas M.C.P.; Kemper E.M.; Dallinga-Thie G.M.; Groen A.K.; Joosten L.A.B.; Netea M.G.; Stroes E.S.G.; de Vos W.M.; Hazen S.L.; Nieuwdorp M.; Effect of ve-gan fecal microbiota transplantation on carnitine\u2010 and choline\u2010derived trimethylamine\u2010n\u2010oxide production and vascular inflammation in patients with metabolic syndrome. J Am Heart Assoc 2018,7(7),e008342","journal-title":"J Am Heart Assoc"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41587-020-0549-5","volume":"38","author":"Chen P.B.","year":"2020","unstructured":"Chen P.B.; Black A.S.; Sobel A.L.; Zhao Y.; Mukherjee P.; Molparia B.; Moore N.E.; Aleman Muench G.R.; Wu J.; Chen W.; Pinto A.F.M.; Maryanoff B.E.; Saghatelian A.; Soroosh P.; Torkamani A.; Leman L.J.; Ghadiri M.R.; Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis. Nat Biotechnol 2020,38(11),1288-1297","journal-title":"Nat Biotechnol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1001\/jama.293.21.2641","volume":"293","author":"Andraws R.","year":"2005","unstructured":"Andraws R.; Berger J.S.; Brown D.L.; Effects of antibiotic therapy on outcomes of patients with coronary artery disease: A meta-analysis of randomized controlled trials. JAMA 2005,293(21),2641-2647","journal-title":"JAMA"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMoa043528","volume":"352","author":"Cannon C.P.","year":"2005","unstructured":"Cannon C.P.; Braunwald E.; McCabe C.H.; Grayston J.T.; Muhlestein B.; Giugliano R.P.; Cairns R.; Skene A.M.; Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005,352(16),1646-1654","journal-title":"N Engl J Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1093\/cid\/civ177","volume":"60","author":"Patel R.","year":"2015","unstructured":"Patel R.; DuPont H.L.; New approaches for bacteriotherapy: Prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis 2015,60(S2),S108-S121","journal-title":"Clin Infect Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/nu10080988","volume":"10","author":"Hiippala K.","year":"2018","unstructured":"Hiippala K.; Jouhten H.; Ronkainen A.; Hartikainen A.; Kainulainen V.; Jalanka J.; Satokari R.; The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients 2018,10(8),988","journal-title":"Nutrients"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1096\/fj.11-197921","volume":"26","author":"Lam V.","year":"2012","unstructured":"Lam V.; Su J.; Koprowski S.; Hsu A.; Tweddell J.S.; Rafiee P.; Gross G.J.; Salzman N.H.; Baker J.E.; Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J 2012,26(4),1727-1735","journal-title":"FASEB J"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1017\/S0007114513001037","volume":"110","author":"Kadooka Y.","year":"2013","unstructured":"Kadooka Y.; Sato M.; Ogawa A.; Miyoshi M.; Uenishi H.; Ogawa H.; Ikuyama K.; Kagoshima M.; Tsuchida T.; Effect of Lactobacil-lus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr 2013,110(9),1696-1703","journal-title":"Br J Nutr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ejcn.2010.19","volume":"64","author":"Kadooka Y.","year":"2010","unstructured":"Kadooka Y.; Sato M.; Imaizumi K.; Ogawa A.; Ikuyama K.; Akai Y.; Okano M.; Kagoshima M.; Tsuchida T.; Regulation of ab-dominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010,64(6),636-643","journal-title":"Eur J Clin Nutr"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.atherosclerosis.2015.06.030","volume":"241","author":"Ahn H.Y.","year":"2015","unstructured":"Ahn H.Y.; Kim M.; Chae J.S.; Ahn Y.T.; Sim J.H.; Choi I.D.; Lee S.H.; Lee J.H.; Supplementation with two probiotic strains, Lactoba-cillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia. Atherosclerosis 2015,241(2),649-656","journal-title":"Atherosclerosis"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1017\/S0007114511004703","volume":"107","author":"Jones M.L.","year":"2012","unstructured":"Jones M.L.; Martoni C.J.; Parent M.; Prakash S.; Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lacto-bacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 2012,107(10),1505-1513","journal-title":"Br J Nutr"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","volume":"135","author":"Marques F.Z.","year":"2017","unstructured":"Marques F.Z.; Nelson E.; Chu P.Y.; Horlock D.; Fiedler A.; Ziemann M.; Tan J.K.; Kuruppu S.; Rajapakse N.W.; El-Osta A.; Mac-kay C.R.; Kaye D.M.; High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 2017,135(10),964-977","journal-title":"Circulation"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/gutjnl-2016-313316","volume":"67","author":"Catry E.","year":"2018","unstructured":"Catry E.; Bindels L.B.; Tailleux A.; Lestavel S.; Neyrinck A.M.; Goossens J.F.; Lobysheva I.; Plovier H.; Essaghir A.; Demoulin J.B.; Bouzin C.; Pachikian B.D.; Cani P.D.; Staels B.; Dessy C.; Delzenne N.M.; Targeting the gut microbiota with inulin-type fructans: Preclinical demonstration of a novel approach in the management of endothelial dysfunction. Gut 2018,67(2),271-283","journal-title":"Gut"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/gutjnl-2012-303304","volume":"62","author":"Dewulf E.M.","year":"2013","unstructured":"Dewulf E.M.; Cani P.D.; Claus S.P.; Fuentes S.; Puylaert P.G.B.; Neyrinck A.M.; Bindels L.B.; de Vos W.M.; Gibson G.R.; Thissen J.P.; Delzenne N.M.; Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013,62(8),1112-1121","journal-title":"Gut"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40168-022-01271-6","volume":"10","author":"Zhou Q.","year":"2022","unstructured":"Zhou Q.; Deng J.; Pan X.; Meng D.; Zhu Y.; Bai Y.; Shi C.; Duan Y.; Wang T.; Li X.; Sluijter J.P.G.; Xiao J.; Gut microbiome medi-ates the protective effects of exercise after myocardial infarction. Microbiome 2022,10(1),82","journal-title":"Microbiome"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","volume":"9","author":"Wang Z.","year":"2018","unstructured":"Wang Z.; Zhao Y.; Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell 2018,9(5),416-431","journal-title":"Protein Cell"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.7150\/thno.55946","volume":"11","author":"Hu X.","year":"2021","unstructured":"Hu X.; Li H.; Zhao X.; Zhou R.; Liu H.; Sun Y.; Fan Y.; Shi Y.; Qiao S.; Liu S.; Liu H.; Zhang S.; Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome. Theranostics 2021,11(12),5778-5793","journal-title":"Theranostics"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s12275-018-8152-x","volume":"56","author":"Sun B.","year":"2018","unstructured":"Sun B.; Li L.; Zhou X.; Comparative analysis of the gut microbiota in distinct statin response patients in East China. J Microbiol 2018,56(12),886-892","journal-title":"J Microbiol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3389\/fmicb.2018.00530","volume":"9","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Song X.; Zhou H.; Zhou X.; Xia Y.; Dong X.; Zhong W.; Tang S.; Wang L.; Wen S.; Xiao J.; Tang L.; Gut microbiome asso-ciates with lipid-lowering effect of rosuvastatin in vivo. Front Microbiol 2018,9,530","journal-title":"Front Microbiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"A115","DOI":"10.1016\/S0735-1097(18)30656-9","volume":"71","author":"Li D.Y.","year":"2018","unstructured":"Li D.Y.; Wang Z.; Li X.S.; Hazen S.L.; Tang W.H.W.; Relationship between statin use and trimethylamine n-oxide in cardiovascular risk assessment. J Am Coll Cardiol 2018,71(11),A115","journal-title":"J Am Coll Cardiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1135","volume":"10","author":"Kong W.","year":"2004","unstructured":"Kong W.; Wei J.; Abidi P.; Lin M.; Inaba S.; Li C.; Wang Y.; Wang Z.; Si S.; Pan H.; Wang S.; Wu J.; Wang Y.; Li Z.; Liu J.; Jiang J.D.; Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004,10(12),1344-1351","journal-title":"Nat Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","volume":"47","author":"Brusq J.M.","year":"2006","unstructured":"Brusq J.M.; Ancellin N.; Grondin P.; Guillard R.; Martin S.; Saintillan Y.; Issandou M.; Inhibition of lipid synthesis through activation of AMP kinase: An additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 2006,47(6),1281-1288","journal-title":"J Lipid Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1517\/14712598.2013.776037","volume":"13","author":"Derosa G.","year":"2013","unstructured":"Derosa G.; D\u2019Angelo A.; Bonaventura A.; Bianchi L.; Romano D.; Maffioli P.; Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert Opin Biol Ther 2013,13(4),475-482","journal-title":"Expert Opin Biol Ther"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-015-0629-3","volume":"13","author":"Li X.Y.","year":"2015","unstructured":"Li X.Y.; Zhao Z.X.; Huang M.; Feng R.; He C.Y.; Ma C.; Luo S.H.; Fu J.; Wen B.Y.; Ren L.; Shou J.W.; Guo F.; Chen Y.; Gao X.; Wang Y.; Jiang J.D.; Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters. J Transl Med 2015,13(1),278","journal-title":"J Transl Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-022-01027-6","volume":"7","author":"Ma S.R.","year":"2022","unstructured":"Ma S.R.; Tong Q.; Lin Y.; Pan L.B.; Fu J.; Peng R.; Zhang X.F.; Zhao Z.X.; Li Y.; Yu J.B.; Cong L.; Han P.; Zhang Z.W.; Yu H.; Wang Y.; Jiang J.D.; Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct Target Ther 2022,7(1),207","journal-title":"Signal Transduct Target Ther"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fphar.2020.00223","volume":"11","author":"Wu M.","year":"2020","unstructured":"Wu M.; Yang S.; Wang S.; Cao Y.; Zhao R.; Li X.; Xing Y.; Liu L.; Effect of berberine on atherosclerosis and gut microbiota modula-tion and their correlation in high-fat diet-fed ApoE\u2212\/\u2212 Mice. Front Pharmacol 2020,11,223","journal-title":"Front Pharmacol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2017.11.023","volume":"268","author":"Zhu L.","year":"2018","unstructured":"Zhu L.; Zhang D.; Zhu H.; Zhu J.; Weng S.; Dong L.; Liu T.; Hu Y.; Shen X.; Berberine treatment increases akkermansia in the gut and improves high-fat diet-induced atherosclerosis in apoe\u2212\/\u2212 mice. Atherosclerosis 2018,268,117-126","journal-title":"Atherosclerosis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/mol.116.106617","volume":"91","author":"Sun R.","year":"2017","unstructured":"Sun R.; Yang N.; Kong B.; Cao B.; Feng D.; Yu X.; Ge C.; Huang J.; Shen J.; Wang P.; Feng S.; Fei F.; Guo J.; He J.; Aa N.; Chen Q.; Pan Y.; Schumacher J.D.; Yang C.S.; Guo G.L.; Aa J.; Wang G.; Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway. Mol Pharmacol 2017,91(2),110-122","journal-title":"Mol Pharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41522-021-00205-8","volume":"7","author":"Li X.","year":"2021","unstructured":"Li X.; Su C.; Jiang Z.; Yang Y.; Zhang Y.; Yang M.; Zhang X.; Du Y.; Zhang J.; Wang L.; Jiang J.; Hong B.; Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbi-ome. NPJ Biofilms Microbiomes 2021,7(1),36","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2017.02.003","volume":"70","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Shou J.W.; Li X.Y.; Zhao Z.X.; Fu J.; He C.Y.; Feng R.; Ma C.; Wen B.Y.; Guo F.; Yang X.Y.; Han Y.X.; Wang L.L.; Tong Q.; You X.F.; Lin Y.; Kong W.J.; Si S.Y.; Jiang J.D.; Berberine-induced bioactive metabolites of the gut microbiota improve ener-gy metabolism. Metabolism 2017,70,72-84","journal-title":"Metabolism"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s00216-019-01793-3","volume":"411","author":"Ma S.R.","year":"2019","unstructured":"Ma S.R.; Tong Q.; Zhao Z.X.; Cong L.; Yu J.B.; Fu J.; Han P.; Pan L.B.; Gu R.; Peng R.; Zhang Z.W.; Wang Y.; Jiang J.D.; Determi-nation of berberine-upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone. Anal Bioanal Chem 2019,411(14),3191-3207","journal-title":"Anal Bioanal Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.apsb.2021.01.009","volume":"11","author":"Shang J.","year":"2021","unstructured":"Shang J.; Ma S.; Zang C.; Bao X.; Wang Y.; Zhang D.; Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson\u2019s dis-ease treatment. Acta Pharm Sin B 2021,11(5),1213-1226","journal-title":"Acta Pharm Sin B"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jpha.2020.10.001","volume":"11","author":"Zhang Z.W.","year":"2021","unstructured":"Zhang Z.W.; Cong L.; Peng R.; Han P.; Ma S.R.; Pan L.B.; Fu J.; Yu H.; Wang Y.; Jiang J.D.; Transformation of berberine to its de-methylated metabolites by the CYP51 enzyme in the gut microbiota. J Pharm Anal 2021,11(5),628-637","journal-title":"J Pharm Anal"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","volume":"11","author":"Zhang X.","year":"2021","unstructured":"Zhang X.; Han Y.; Huang W.; Jin M.; Gao Z.; The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B 2021,11(7),1789-1812","journal-title":"Acta Pharm Sin B"},{"key":"ref=111","first-page":"330","volume":"121","author":"Vick R.L.","year":"1957","unstructured":"Vick R.L.; Kahn J.B.; Acheson G.H.; Effects of dihydro-ouabain, dihydrodigoxin and dihydrodigitoxin on the heart-lung preparation of the dog. J Pharmacol Exp Ther 1957,121(3),330-339","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJM198110013051403","volume":"305","author":"Lindenbaum J.","year":"1981","unstructured":"Lindenbaum J.; Rund D.G.; Butler V.P.; Tse-Eng D.; Saha J.R.; Inactivation of digoxin by the gut flora: Reversal by antibiotic thera-py. N Engl J Med 1981,305(14),789-794","journal-title":"N Engl J Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4149\/gpb_2013034","volume":"32","author":"Smetanov\u00e1 L.","year":"2014","unstructured":"Smetanov\u00e1 L.; \u0160t\u011btinov\u00e1 V.; Kholov\u00e1 D.; Kune\u0161 M.; Nobilis M.; Svoboda Z.; Kv\u011btina J.; Transintestinal transport mechanisms of 5-aminosalicylic acid (in situ rat intestine perfusion, Caco-2 cells) and Biopharmaceutics Classification System. Gen Physiol Biophys 2014,32(3),361-369","journal-title":"Gen Physiol Biophys"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1002\/jps.24103","volume":"103","author":"Sousa T.","year":"2014","unstructured":"Sousa T.; Yadav V.; Zann V.; Borde A.; Abrahamsson B.; Basit A.W.; On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid. J Pharm Sci 2014,103(10),3171-3175","journal-title":"J Pharm Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","volume":"12","author":"Chen W.","year":"2011","unstructured":"Chen W.; Miao Y.Q.; Fan D.J.; Yang S.S.; Lin X.; Meng L.K.; Tang X.; Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech 2011,12(2),705-711","journal-title":"AAPS PharmSciTech"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"12155","DOI":"10.1038\/srep12155","volume":"5","author":"Feng R.","year":"2015","unstructured":"Feng R.; Shou J.W.; Zhao Z.X.; He C.Y.; Ma C.; Huang M.; Transforming berberine into its intestine-absorbable form by the gut micro-biota. Sci Rep 2015,5,12155","journal-title":"Sci Rep"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.7150\/thno.18290","volume":"7","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Tong Q.; Shou J.W.; Zhao Z.X.; Li X.Y.; Zhang X.F.; Ma S.R.; He C.Y.; Lin Y.; Wen B.Y.; Guo F.; Fu J.; Jiang J.D.; Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine. Theranostics 2017,7(9),2443-2451","journal-title":"Theranostics"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijantimicag.2016.09.026","volume":"49","author":"Demonfort Nkamga V.","year":"2017","unstructured":"Demonfort Nkamga V.; Armstrong N.; Drancourt M.; In vitro susceptibility of cultured human methanogens to lovastatin. Int J Antimicrob Agents 2017,49(2),176-182","journal-title":"Int J Antimicrob Agents"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1124\/dmd.114.058354","volume":"42","author":"Yoo D.H.","year":"2014","unstructured":"Yoo D.H.; Kim I.S.; Van Le T.K.; Jung I.H.; Yoo H.H.; Kim D.H.; Gut microbiota-mediated drug interactions between lovastatin and antibiotics. Drug Metab Dispos 2014,42(9),1508-1513","journal-title":"Drug Metab Dispos"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","volume":"12","author":"Li H.","year":"2016","unstructured":"Li H.; He J.; Jia W.; The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 2016,12(1),31-40","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389200224666230410094806","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215594\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389200224666230410094806","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T12:36:20Z","timestamp":1700051780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215594\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":120,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389200224666230410094806","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}